Joensuu H - Search Results

1

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB. Hauptmann M, et al. Among authors: joensuu h. Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6. Br J Cancer. 2016. PMID: 27599043 Free PMC article.

2

Long-term survival after pancreatic adenocarcinoma--often a misdiagnosis?

Alanen KA, Joensuu H. Alanen KA, et al. Among authors: joensuu h. Br J Cancer. 1993 Nov;68(5):1004-5. doi: 10.1038/bjc.1993.469. Br J Cancer. 1993. PMID: 8217587 Free PMC article.

3

Does the month of diagnosis affect survival of cancer patients?

Sankila R, Joensuu H, Pukkala E, Toikkanen S. Sankila R, et al. Among authors: joensuu h. Br J Cancer. 1993 Apr;67(4):838-41. doi: 10.1038/bjc.1993.153. Br J Cancer. 1993. PMID: 8471442 Free PMC article.

4

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer.

Salven P, Ruotsalainen T, Mattson K, Joensuu H. Salven P, et al. Among authors: joensuu h. Int J Cancer. 1998 Apr 17;79(2):144-6. doi: 10.1002/(sici)1097-0215(19980417)79:2<144::aid-ijc8>3.0.co;2-t. Int J Cancer. 1998. PMID: 9583728 Free article. Clinical Trial.

5

Repopulation during radical radiotherapy for T1 glottic cancer.

Saarilahti K, Kajanti M, Lehtonen H, Hämäläinen T, Joensuu H. Saarilahti K, et al. Among authors: joensuu h. Radiother Oncol. 1998 May;47(2):155-9. doi: 10.1016/s0167-8140(97)00222-3. Radiother Oncol. 1998. PMID: 9683363

6

Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC.

Isokangas OP, Joensuu H, Halme M, Jekunen A, Mattson K. Isokangas OP, et al. Among authors: joensuu h. Lung Cancer. 1998 May;20(2):127-33. doi: 10.1016/s0169-5002(98)00025-7. Lung Cancer. 1998. PMID: 9711531 Clinical Trial.

7

Long-term survival in node-positive breast cancer treated by locoregional therapy alone.

Joensuu H, Pylkkänen L, Toikkanen S. Joensuu H, et al. Br J Cancer. 1998 Sep;78(6):795-9. doi: 10.1038/bjc.1998.581. Br J Cancer. 1998. PMID: 9743303 Free PMC article.

8

Second cancer among long-term survivors from Hodgkin's disease.

Nyandoto P, Muhonen T, Joensuu H. Nyandoto P, et al. Among authors: joensuu h. Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):373-8. doi: 10.1016/s0360-3016(98)00217-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9788418

9

Syndecan-1 expression has prognostic significance in head and neck carcinoma.

Anttonen A, Kajanti M, Heikkilä P, Jalkanen M, Joensuu H. Anttonen A, et al. Among authors: joensuu h. Br J Cancer. 1999 Feb;79(3-4):558-64. doi: 10.1038/sj.bjc.6690088. Br J Cancer. 1999. PMID: 10027330 Free PMC article.

10

Late mortality from pT1N0M0 breast carcinoma.

Joensuu H, Pylkkänen L, Toikkanen S. Joensuu H, et al. Cancer. 1999 May 15;85(10):2183-9. doi: 10.1002/(sici)1097-0142(19990515)85:10<2183::aid-cncr12>3.0.co;2-k. Cancer. 1999. PMID: 10326696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

610 results

Search Page